Literature DB >> 32062709

Pregnancy-induced hypertension, preterm birth, and cord blood adipokine levels.

Elizabeth Soares da Silva Magalhães1, Maria Dalva Barbosa Baker Méio2, Fernando Maia Peixoto-Filho3, Sayonara Gonzalez4, Ana Carolina Carioca da Costa2, Maria Elisabeth Lopes Moreira2.   

Abstract

Maternal hypertension may alter physiological parameters, dysregulating the release of hormones such as adipokines, thus influencing the fetal growth course. This study investigated whether hypertensive disorders of pregnancy alter cord blood adipokine levels and correlate these with anthropometric parameters in preterm infants. This is a prospective cohort study with pregnant women < 37-week gestation with and without hypertension and their offspring. Cord blood leptin, adiponectin, and ghrelin were analyzed by LUMINEX®. These adipokines were compared between the groups exposed or not to gestational hypertension using non-parametric statistical tests. The hypertensive pregnancies had significantly higher cord blood leptin (1.00 (IQR 0.67-1.20 ng/mL)) and adiponectin (18.52 (IQR 17.52-25.13 μg/mL)) levels than those without hypertension (0.07 (IQR 0.06-0.08 ng/mL) and 8.13 (IQR 6.50-8.68 μg/mL), respectively, p < 0.0001). The adipokine levels were higher in AGA and SGA infants in the exposed group for both moderate and late preterm. SGA had significantly higher ghrelin levels than the AGA infants. Ghrelin levels were negatively correlated with birth weight (r = - 0.613, p < 0.001), birth length (r = - 0.510, p < 0.001), head circumference (- 0.346, p < 0.002), and gestational age (r = - 0.612, p < 0.001).Conclusions: Our findings demonstrate an increase in adipokine levels in the cord blood of preterm newborn infants exposed to maternal hypertension. What is Known: • Clinical evidence suggests that concentration of the serum adipokines may be affected by risk of hypertension in both adults and pregnant women. • Maternal profile as hypertension alters intrauterine environment and could affect the function of fetal metabolism, impairing fetal growth. What is New: • Gestational hypertension modifies the adipokine profile, with higher rates already present at birth in cord blood samples. • Within the hypertensive group and stratifying for gestation age, ghrelin concentrations were higher in SGA newborns, both in the moderate and late preterm, compared with AGA newborns.

Entities:  

Keywords:  Adiponectin; Ghrelin; Intrauterine growth restriction; Leptin; Pregnancy-induced hypertension; Preterm

Year:  2020        PMID: 32062709     DOI: 10.1007/s00431-020-03586-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Periodontal disease and preterm delivery: a nationwide population-based cohort study of Taiwan.

Authors:  Ya-Ling Lee; Hsiao-Yun Hu; Sin-Yi Chou; Chen-Li Lin; Feng-Shiang Cheng; Chia-Yi Yu; Dachen Chu
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.379

Review 2.  The Role of the Gastric Hormones Ghrelin and Nesfatin-1 in Reproduction.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

3.  The influence of gestational hypertension on cord blood adiponectin levels: a case-controlled study.

Authors:  Justyna Czubilińska-Łada; Aleksandra Gliwińska; Elżbieta Świȩtochowska; Lucyna Nowak-Borzȩcka; Beata Sadownik; Jakub Behrendt; Maria Szczepańska
Journal:  Ther Adv Endocrinol Metab       Date:  2021-11-30       Impact factor: 3.565

4.  Associations Among Maternal Metabolic Conditions, Cord Serum Leptin Levels, and Autistic Symptoms in Children.

Authors:  Toshiki Iwabuchi; Nagahide Takahashi; Tomoko Nishimura; Md Shafiur Rahman; Taeko Harada; Akemi Okumura; Hitoshi Kuwabara; Shu Takagai; Yoko Nomura; Hideo Matsuzaki; Norio Ozaki; Kenji J Tsuchiya
Journal:  Front Psychiatry       Date:  2022-02-03       Impact factor: 4.157

5.  Impact of gestational hypertension and pre-eclampsia on preterm birth in China: a large prospective cohort study.

Authors:  Hang An; Ming Jin; Zhiwen Li; Le Zhang; Hongtian Li; Yali Zhang; Rongwei Ye; Nan Li
Journal:  BMJ Open       Date:  2022-09-27       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.